Next Article in Journal
Evolution of Endogenous Retroviruses in the Subfamily of Caprinae
Previous Article in Journal
The Multi-Kingdom Microbiome of Wintering Migratory Birds in Poyang Lake, China
Previous Article in Special Issue
Ocular Symptoms Associated with COVID-19 Are Correlated with the Expression Profile of Mouse SARS-CoV-2 Binding Sites
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429

1
Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USA
2
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USA
3
Department of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
4
Office of Research, Campus Veterinary Services, University of California-Davis, Davis, CA 95616, USA
5
Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616, USA
6
Sporos Bioventures, @JLABS Suite 201, 2450 Holcombe Blvd, Houston, TX 77021, USA
*
Author to whom correspondence should be addressed.
Viruses 2024, 16(3), 397; https://doi.org/10.3390/v16030397
Submission received: 19 February 2024 / Accepted: 19 February 2024 / Published: 4 March 2024
(This article belongs to the Special Issue Coronaviruses across Species, a Comparative Approach)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the original publication [...]

Share and Cite

MDPI and ACS Style

Cook, S.; Wittenburg, L.; Yan, V.C.; Theil, J.H.; Castillo, D.; Reagan, K.L.; Williams, S.; Pham, C.-D.; Li, C.; Muller, F.L.; et al. Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429. Viruses 2024, 16, 397. https://doi.org/10.3390/v16030397

AMA Style

Cook S, Wittenburg L, Yan VC, Theil JH, Castillo D, Reagan KL, Williams S, Pham C-D, Li C, Muller FL, et al. Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429. Viruses. 2024; 16(3):397. https://doi.org/10.3390/v16030397

Chicago/Turabian Style

Cook, Sarah, Luke Wittenburg, Victoria C. Yan, Jacob H. Theil, Diego Castillo, Krystle L. Reagan, Sonyia Williams, Cong-Dat Pham, Chun Li, Florian L. Muller, and et al. 2024. "Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429" Viruses 16, no. 3: 397. https://doi.org/10.3390/v16030397

APA Style

Cook, S., Wittenburg, L., Yan, V. C., Theil, J. H., Castillo, D., Reagan, K. L., Williams, S., Pham, C.-D., Li, C., Muller, F. L., & Murphy, B. G. (2024). Correction: Cook et al. An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats. Viruses 2022, 14, 2429. Viruses, 16(3), 397. https://doi.org/10.3390/v16030397

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop